Veterinary Pharmaceutical Solutions
Veterinary Pharmaceutical Solutions, often referred to as VPS, is a leading provider of innovative veterinary pharmaceuticals headquartered in the United States. Established in 2005, the company has made significant strides in the veterinary industry, focusing on the development and distribution of high-quality medications for companion animals and livestock. With a strong presence across North America and expanding operations in Europe, VPS is renowned for its unique formulations and commitment to animal health. Their core product offerings include anti-infectives, analgesics, and vaccines, all designed to enhance the well-being of animals while ensuring compliance with regulatory standards. VPS has earned a notable reputation for its dedication to research and development, positioning itself as a trusted partner for veterinarians and animal health professionals. Through continuous innovation and a customer-centric approach, Veterinary Pharmaceutical Solutions remains at the forefront of the veterinary pharmaceutical market.
DitchCarbon Score
How does Veterinary Pharmaceutical Solutions's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Veterinary Pharmaceutical Solutions's score of 31 is higher than 52% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Veterinary Pharmaceutical Solutions's reported carbon emissions
In 2022, Veterinary Pharmaceutical Solutions reported total carbon emissions of approximately 303,186,000 kg CO2e, comprising 112,577,000 kg CO2e from Scope 1 emissions and 190,609,000 kg CO2e from Scope 2 emissions. This marked an increase from 2021, where total emissions were about 288,208,000 kg CO2e, with Scope 1 at 101,498,000 kg CO2e and Scope 2 at 186,710,000 kg CO2e. The company has not disclosed any Scope 3 emissions data. Veterinary Pharmaceutical Solutions has set ambitious climate commitments, aiming for carbon neutrality in its operations by 2030, specifically targeting reductions in Scope 1 and 2 emissions from manufacturing, research and development, office locations, and fleet vehicles. Additionally, the company is working towards a 5% reduction in energy intensity in its manufacturing and R&D processes by 2025, using 2019 as a baseline. These initiatives reflect the company's commitment to sustainability and align with industry standards for climate action.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|---|---|
| Scope 1 | 2,539,110 | 0,000,000 | 0,000,000 | - | 00,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 2,035,306 | 0,000,000 | 0,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | - | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Veterinary Pharmaceutical Solutions is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
